Trial Profile
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary) ; Travoprost
- Indications Angle-closure glaucoma; Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Santen S.A.S.
- 19 May 2014 New trial record